NAMREPLI Trademark

Trademark Overview

On Wednesday, January 22, 2020, a trademark application was filed for NAMREPLI with the United States Patent and Trademark Office. The USPTO has given the NAMREPLI trademark a serial number of 88768537. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 21, 2023. This trademark is owned by Gamida Cell Inc.. The NAMREPLI trademark is filed in the Pharmaceutical Products category with the following description:

Cell therapy preparations for the treatment of hematology, oncology, leukemia, and blood and bone marrow diseases and disorders; pharmaceutical preparations in the field of hematology, oncology, leukemia, and blood and bone marrow diseases and disorders
namrepli

General Information

Serial Number88768537
Word MarkNAMREPLI
Filing DateWednesday, January 22, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 21, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 24, 2020

Trademark Statements

Goods and ServicesCell therapy preparations for the treatment of hematology, oncology, leukemia, and blood and bone marrow diseases and disorders; pharmaceutical preparations in the field of hematology, oncology, leukemia, and blood and bone marrow diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, January 25, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGamida Cell Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02116
Party NameGamida Cell Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02116

Trademark Events

Event DateEvent Description
Monday, August 21, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 21, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 23, 2022SOU EXTENSION 4 GRANTED
Friday, December 23, 2022SOU EXTENSION 4 FILED
Friday, December 23, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, July 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 15, 2022SOU EXTENSION 3 GRANTED
Friday, July 15, 2022SOU EXTENSION 3 FILED
Friday, July 15, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, February 15, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 15, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, February 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 15, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 18, 2022SOU EXTENSION 2 GRANTED
Tuesday, January 18, 2022SOU EXTENSION 2 FILED
Tuesday, January 18, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, July 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 9, 2021SOU EXTENSION 1 GRANTED
Friday, July 9, 2021SOU EXTENSION 1 FILED
Friday, July 9, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, January 19, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 24, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 24, 2020PUBLISHED FOR OPPOSITION
Wednesday, November 4, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 16, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 16, 2020EXAMINER'S AMENDMENT ENTERED
Friday, October 16, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, October 16, 2020EXAMINERS AMENDMENT E-MAILED
Friday, October 16, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, October 15, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 15, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 15, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 17, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 17, 2020NON-FINAL ACTION E-MAILED
Friday, April 17, 2020NON-FINAL ACTION WRITTEN
Friday, April 10, 2020ASSIGNED TO EXAMINER
Saturday, January 25, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 25, 2020NEW APPLICATION ENTERED

Related Keywords

namrepli bone marrow diseases disorders blood leukemia preparations hematology oncology field